Intradialysis Exercise Functional Capacity, Body Composition and Survival in Hemodialysis Patients
NCT ID: NCT06788054
Last Updated: 2025-01-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
50 participants
INTERVENTIONAL
2025-01-20
2026-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Therefore, this study aims to determine the effect of a 12-week supervised physical exercise program during hemodialysis on strength and ability to move, the amount of fat and muscle in the body, as well as bone wear. ; and compare these results with a group of patients who do not perform supervised exercise. In addition, it will be determined how exercise can act in the long term, preventing the risk of hospitalization and death due to cardiovascular causes. The above is useful in order to establish recommendations and protocols that help us increase the quality of life and survival of the person.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Intradialytic Exercise on the Physical Function of People Undergoing Hemodialysis
NCT03944824
Effects of Resistance Training on Physical Activity in Daily Life and Functional Capacity in Hemodialysis Patients
NCT02651025
Long Term Physical Activity for Hemodialysis Patients
NCT02860312
Interdialytic Resistance Exercises in with Chronic Kidney Diseases
NCT06862336
Efficacy of an Intradialysis Combined Training Program on Disability Level and Physical Performance.
NCT02883309
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
This clinical trial will be carried out based on the design of groups of HD patients assigned in a randomized manner; The intervention group will receive an intradialysis aerobic exercise and muscular endurance program during the second hour of dialysis, with a frequency of three times a week during; The second group (control group) will not receive intradialytic exercise, although they will receive guidance to carry out a standard treatment, in which they will be recommended to perform aerobic and muscular resistance exercise in their homes at a frequency of three times a week, for 12 weeks .
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients with chronic kidney disease on hemodialysis with intradialytic exercise
intradialysis exercise
moderate intensity aerobic and muscular resistance exercise protocol lasting 12 weeks
patients with chronic kidney disease on hemodialysis without intradialytic exercise
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
intradialysis exercise
moderate intensity aerobic and muscular resistance exercise protocol lasting 12 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients who receive regular hemodialysis sessions 3 times a week, reported through the clinical record.
3. Patients with a clinical history of being treated with HD for at least 1 previous year (reported by clinical record).
4. Patients without a history of myocardial infarction in the last 3 months (reported by clinical record).
5. Patients who are not in a kidney transplant protocol to be performed during the next 12 months.
6. Patients who have permission from their nephrology specialist to participate.
7. Patients who agree to participate in the study, and who voluntarily sign the informed consent (IC) form.
8. Patients without a history of coronary artery disease in the last 4 months (reported by clinical record).
9. Patients without myocardial instability (angina, decompensated congestive heart failure, severe arteriovenous stenosis, uncontrolled arrhythmias), reported by clinical record.
10. Patients without active infectious process (reported by clinical record).
11. Patients without extreme changes in blood glucose levels (hyperglycemia or hypoglycemia), reported by clinical record.
12. Patients without neurological, respiratory or skeletal muscle diseases or disorders that are aggravated by exercise (reported by clinical record).
13. Patients without inability to sit, stand or walk without assistance (walking device such as cane or walker is allowed) self-reported.
14. Patients without severe anemia (Hb \< 8.0 g/dL), reported by clinical record.
15. Female patients should not be under sex hormone treatment or hormone replacement therapy for menopause (self-reported).
16. Patients without lupus erythematosus as the etiology of CKD, reported by clinical record.
17. Physically inactive (Do not perform physical exercise of more than 150 minutes per week on a regular basis according to data from the World Health Organization).
18. Patients who do not have amputations of any of the extremities.
Exclusion Criteria
2. When the patient voluntarily decides to leave the study.
3. When the patient begins additional strength or aerobic training.
4. Patients who receive a kidney transplant during the development of the exercise protocol or follow-up during the 8-month follow-up period.
5. Patients who decide to belong to the group that will perform intradialytic exercise.
6. When for any reason the exercise is suspended for more than three continuous times.
18 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad de Guanajuato
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Martha Jocelyne Piñon Ruiz
principal researcher
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Departamento de Ciencias Médicas Universidad de Guanajuato
León, Guanajuato, Mexico
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CEPIUG-P59-2024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.